{"id":330343,"date":"2025-10-25T00:27:10","date_gmt":"2025-10-25T00:27:10","guid":{"rendered":"https:\/\/www.europesays.com\/us\/330343\/"},"modified":"2025-10-25T00:27:10","modified_gmt":"2025-10-25T00:27:10","slug":"prebys-ventures-invests-5-million-in-five-san-diego-healthcare-startups","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/330343\/","title":{"rendered":"Prebys Ventures invests $5 million in five San Diego healthcare startups"},"content":{"rendered":"

\"Aspen<\/a>One of startups, Aspen Neuroscience, is using robotic technology to manufacture stem cell therapies for Parkinson\u2019s disease. (Photo from company video)<\/p>\n

Prebys Ventures<\/a> announced this week it has invested $5 million into five San Diego startup companies working on the cutting edge of healthcare research and development. <\/p>\n

The venture fund created by San Diego\u2019s largest private foundation made separate $1 million investments in\u00a0AeroRX<\/a>,\u00a0Aspen Neuroscience<\/a>,\u00a0Crystalys Therapeutics,<\/a>\u00a0Protalys Pharmaceuticals<\/a>, and\u00a0Welby Health<\/a>.\u00a0\u00a0<\/p>\n

The companies are developing solutions for chronic obstructive pulmonary disease (COPD), Parkinson\u2019s disease, gout, oncology, and chronic care management.<\/p>\n

The funding comes at a time when venture investing is largely stalled\u00a0\u00a0across the nation.<\/p>\n

\u201cWe\u2019re very excited not only about the cutting-edge innovation of these five companies, but for what this means for San Diego\u2019s entire innovation sector,\u201d said Prebys Ventures Managing Director Mike Krenn. \u201cAt a time when investors are scaling back, we\u2019re proud to be working to advance health technology while investing in the future of San Diego.\u201d\u00a0\u00a0\u00a0 \u00a0<\/p>\n

Krenn added part of the fund\u2019s vision is to attract more outside capital to the region, noting they\u2019ve already brought a new investor to San Diego with one of their portfolio companies.\u00a0<\/p>\n

\u201cWe\u2019re already actively sharing San Diego deal flow with outside investors, and we\u2019ll continue to do so. We\u2019re also very pleased with the incredibly well-regarded and established funds we\u2019ve been able to invest alongside thus far, and we\u2019re hoping to collaborate on more deals in the future,\u201d he said.<\/p>\n

Prebys Ventures was created earlier this year<\/a> by the Prebys Foundation<\/a> with a goal of investing $50 million into private ventures to grow capital that is in turn reinvested back into San Diego communities.\u00a0<\/p>\n

\u201cWe believe the innovation economy will play a vital role in San Diego\u2019s future, opening up economic opportunity across our region,\u201d said Prebys Foundation CEO Grant Oliphant. \u201cWe know that every innovation economy job creates 2.6 other jobs in the region.\u201d\u00a0\u00a0<\/p>\n

He said he believed the fund would become a model for other foundations.<\/p>\n

READ NEXT\n\t<\/p>\n","protected":false},"excerpt":{"rendered":"One of startups, Aspen Neuroscience, is using robotic technology to manufacture stem cell therapies for Parkinson\u2019s disease. (Photo…\n","protected":false},"author":3,"featured_media":330344,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[5134],"tags":[5229,1582,276,164047,1184,164048,7585,164049,3549,7264,67,586,132,5230,68,2969,164050],"class_list":["post-330343","post","type-post","status-publish","format-standard","has-post-thumbnail","category-san-diego","tag-america","tag-ca","tag-california","tag-innovation-economy","tag-medicine","tag-mike-krenn","tag-prebys-foundation","tag-prebys-ventures","tag-san-diego","tag-sandiego","tag-united-states","tag-united-states-of-america","tag-unitedstates","tag-unitedstatesofamerica","tag-us","tag-usa","tag-venture-fund"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115431974074088086","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/330343","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=330343"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/330343\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/330344"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=330343"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=330343"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=330343"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}